Response to preoperative short-course radiotherapy in locally advanced rectal cancer: Value of 18F-fluorodeoxyglucose positron emission tomography

Onkologie

Volumn 31, Issue 4, 2008, Pages 166-172

  Siegel, Robert ^a   Dresel, Stefan ^b   Koswig, Stephan ^b   Gebauer, Bernhard ^a   Hünerbein, Michael ^a   Schneider, Wolfgang ^c   Schlag, Peter M ^a,b  

^a Section of Pathology   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c HELIOS KLINIKUM BERLIN BUCH   (Germany)

Author keywords

FDG PET; Preoperative radiotherapy; Rectal cancer; Response assessment

Indexed keywords

FLUORODEOXYGLUCOSE F 18; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTINUOUS INFUSION; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MONITORING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE PERIOD; RADIATION DOSE; RECTUM CANCER; SHORT COURSE THERAPY; TREATMENT RESPONSE; TUMOR REGRESSION; ULTRASOUND;

ADULT; AGED; AGED, 80 AND OVER; ATTITUDE OF HEALTH PERSONNEL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INTERNATIONALITY; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PREOPERATIVE CARE; RADIOPHARMACEUTICALS; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; TREATMENT OUTCOME;

EID: 43949124823     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000118037     Document Type: Article

References (26)

1. NIH consensus conference: Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990;264(11):1444-1450.
2. Camma C, Giunta M, Fiorica F, Pagliaro L, Craxi A, Cottone M: Preoperative radiotherapy for resectable rectal cancer: a meta-analysis. JAMA 2000;284:1008-1015.
3. Kapiteijn E, Marijnen CAM, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJT, Pahlman L, Glimelius B, van Krieken JH, Leer JWH, van de Velde CJH, the Dutch Colorectal Cancer Group: Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345:638-646.
4. Swedish Rectal CT: Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 1997;336:980-987.
5. Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R, the German Rectal Cancer Study Group: Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731-1740.
6. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Kryj M: Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 2006;93:1215-1223.
7. Schlag PM, Budach V, Wernicke KD: Prospective randomized study of preoperative short-course radiotherapy versus neoadjuvant chemoradiotherapy for uT2-3 rectal cancer. Approved Protocol, Berlin, 2003 (ISRCTN56463377).
8. Engelen SM, Beets GL, Beets-Tan RG: Role of preoperative local and distant staging in rectal cancer. Onkologie 2007;30:141-145.
9. Kelloff GJ, Hoffman JM, Johnson B, Scher HI, Siegel BA, Cheng EY, Cheson BD, O'Shaughnessy J, Guyton KZ, Mankoff DA, Shankar L, Larson SM, Sigman CC, Schilsky RL, Sullivan DC: Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development. Clin Cancer Res 2005;11:2785-2808.
10. Kostakoglu L, Coleman M, Leonard JP, Kuji I, Zoe H, Goldsmith SJ: PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin's disease. J Nucl Med 2002;43:1018-1027.
11. Maisey NR, Webb A, Flux GD, Padhani A, Cunningham DC, Ott RJ, Norman A: FDG-PET in the prediction of survival of patients with cancer of the pancreas: a pilot study. Br J Cancer 2000;83:287-293.
12. Weber WA, Ott K, Becker K, Dittler HJ, Helmberger H, Avril NE, Meisetschlager G, Busch R, Siewert JR, Schwaiger M, Fink U: Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. J Clin Oncol 2001;19:3058-3065.
13. Wieder HA, Brucher BL, Zimmermann F, Becker K, Lordick F, Beer A, Schwaiger M, Fink U, Siewert JR, Stein HJ, Weber WA: Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment. J Clin Oncol 2004;22:900-908.
14. Bokemeyer C, Kollmannsberger C, Oechsle K, Dohmen BM, Pfannenberg A, Claussen CD, Bares R, Kanz L: Early prediction of treatment response to high-dose salvage chemotherapy in patients with relapsed germ cell cancer using [(18)F]FDG PET. Br J Cancer 2002;86:506-511.
15. Amthauer H, Denecke T, Rau B, Hildebrandt B, Hunerbein M, Ruf J, Schneider U, Gutberlet M, Schlag PM, Felix R, Wust P: Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: correlation with endorectal ultrasound and histopathology. Eur J Nucl Med Mol Imaging 2004;31:811-819.
16. Calvo FA, Domper M, Matute R, Martinez-Lazaro R, Arranz JA, Desco M, Alvarez E, Carreras JL: 18F-FDG positron emission tomography staging and restaging in rectal cancer treated with pre-operative chemoradiation. Int J Radiat Oncol Biol Phys 2004;58:528-535.
17. Heriot AG, Hicks RJ, Drummond EG, Keck J, Mackay J, Chen F, Kalff V: Does positron emission tomography change management in primary rectal cancer? A prospective assessment. Dis Colon Rectum 2004;47:451-458.
18. Guillem JG, Moore HG, Akhurst T, Klimstra DS, Ruo L, Mazumdar M, Minsky BD, Saltz L, Wong WD, Larson S: Sequential preoperative fluorodeoxyglucose- positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer. J Am Coll Surg 2004;199:1-7.
19. Cascini GL, Avallone A, Delrio P, Guida C, Tatangelo F, Marone P, Aloj L, De Martinis F, Comella P, Parisi V, Lastoria S: 18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer. J Nucl Med 2006;47:1241-1248.
20. Sobin LH, Wittekind Ch (eds): International Union Against Cancer (UICC). TNM Classification of Malignant Tumors, 6th ed. New York, J. Wiley and Sons, 2002.
21. Widder J, Sedlmayer F, Stanek C, Potter R: Quality assurance in preoperative radiotherapy of rectal cancer: evaluation of a pre-trial dummy-run. Radiother Oncol 2000;56:341-347.
22. Dworak O, Keilholz L, Hoffmann A: Pathological features of rectal cancer after preoperative radio-chemotherapy. Int J Colorectal Dis 1997;12:19-23.
23. Young H, Baum R, Cremerius U, Herholz K, Hoekstra O, Lammertsma AA, Pruim J, Price P: Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. Eur J Cancer 1999;35:1773-1782.
24. Glimelius B, Gronberg H, Jarhult J, Wallgren A, Cavallin-Stahl E: A systematic overview of radiation therapy effects in rectal cancer. Acta Oncol 2003;42:476-492.
25. Schiepers C, Haustermans K, Geboes K, Filez L, Bormans G, Penninckx F: The effect of preoperative radiation therapy on glucose utilization and cell kinetics in patients with primary rectal carcinoma. Cancer 1999;85:803-811.
26. Nagtegaal ID, Marijnen CA, Kranenbarg EK, Mulder-Stapel A, Hermans J, van de Velde CJ, van Krieken JH: Short-term preoperative radiotherapy interferes with the determination of pathological parameters in rectal cancer. J Pathol 2002;197:20-27.